Achieve Superior Engraftment in Mice Models with CGT Global
Trusted Supplier of CD34+ Cells for Humanized Mice Studies
Fresh, Fast, and Isolated: CD34+ Cells from Cord Blood
Get high-viability CD34+ cells for your xenograft and immunotherapy models, isolated within 24 hours.
- Thousands of cord blood units isolated annually across FDA-registered sites
- Isolated within 24 hours in state-of-the-art labs
- High-purity CD34+ HSPCs for reliable engraftment and immune reconstitution
- Available fresh or cryopreserved, shipped on your timeline
Built for Humanized Mouse Model Success
Our CD34+ cells are widely used in xenograft and immune system reconstitution models, including:
- HIS (Human Immune System) mice
- Hematopoiesis and engraftment studies
- In vivo immunotherapy and infectious disease modeling
- Gene editing and stem cell expansion research
Whether you're developing CAR-T therapies, testing monoclonal antibodies, or investigating graft-versus-host disease (GVHD), CGT Global delivers the human stem cells you need—when and how you need them.
Reliable, High-Yield CD34+ Cells: Bone Marrow–Derived and Research-Ready
Accelerate your preclinical models with high-purity CD34+ hematopoietic stem and progenitor cells (HSPCs) collected from healthy donors across the U.S.
-
Bone marrow collected on-demand at CGT Global donor centers in Boston, MA, Folsom, CA, and Northeastern PA
-
Same-day processing in FDA-registered, GMP-compliant facilities
-
Isolated CD34+ cells available fresh or cryopreserved to meet your study timeline
-
High-purity, high-viability HSPCs for robust engraftment and consistent results
Built for Humanized Mouse Model Success
Our bone marrow–derived CD34+ cells are widely used in a range of preclinical and translational research models, including:
-
Humanized immune system (HIS) mouse models
-
Xenograft and hematopoietic engraftment studies
-
Cell therapy validation and immuno-oncology development
-
GVHD, gene editing, and stem cell expansion protocols
Whether you’re modeling human immune responses, evaluating biologics, or developing the next generation of CAR-T therapies, CGT Global ensures you get the cells you need—fast, fresh, and tailored to your workflow.
Reliable, High-Yield CD34+ Cells: Bone Marrow–Derived and Research-Ready
Accelerate your preclinical models with high-purity CD34+ hematopoietic stem and progenitor cells (HSPCs) collected from healthy donors across the U.S.
-
Bone marrow collected on-demand at CGT Global donor centers in Boston, MA, Folsom, CA, and Northeastern PA
-
Same-day processing in FDA-registered, GMP-compliant facilities
-
Isolated CD34+ cells available fresh or cryopreserved to meet your study timeline
-
High-purity, high-viability HSPCs for robust engraftment and consistent results
Built for Humanized Mouse Model Success
Our bone marrow–derived CD34+ cells are widely used in a range of preclinical and translational research models, including:
-
Humanized immune system (HIS) mouse models
-
Xenograft and hematopoietic engraftment studies
-
Cell therapy validation and immuno-oncology development
-
GVHD, gene editing, and stem cell expansion protocols
Whether you’re modeling human immune responses, evaluating biologics, or developing the next generation of CAR-T therapies, CGT Global ensures you get the cells you need—fast, fresh, and tailored to your workflow.